{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["alpha lipoic acid", "intraforaminal infiltration", "low-back pain", "myrrh", "oxygen-ozone", "palmitoylethanolamide", "steroid"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36672581", "DateRevised": {"Year": "2023", "Month": "01", "Day": "23"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "12", "Day": "28"}], "ELocationID": ["73", "10.3390/biomedicines11010073"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "28"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "New Approach to Chronic Back Pain Treatment: A Case Control Study.", "Abstract": {"AbstractText": ["Our study compares the clinical outcome of chronic low back pain present for over six months treated with alpha-lipoic acid (ALA) + palmitoylethanolamide (PEA) and myrrh and periradicular infiltrations of oxygen-ozone under CT guide to periradicular steroidal infiltrations in a short (one week), medium (three months) and long-term period (six months).", "We enrolled 246 patients (Group A) with low back pain treated with periradicular infiltrations of oxygen-ozone under CT guide combined with 800 mg/day of ALA + 600 mg/day of PEA + 200 mg/day of myrrh orally. Group B consisted of 176 patients with low back pain treated with periradicular infiltrations of steroids. Patients were clinically monitored one week after the end of treatment, at three months, and at six months using a modified version of McNab's method.", "In Group A, the one-week clinical follow-up registered a complete remission of painful symptoms in 206 patients (83.7%), and this manifestation remained optimal in 191 patients at the three-month follow-up (77.6%) and in 178 at six months (72.3%). While the results were satisfactory in 28 patients (10.9%) at one week, 32 (13%) in the medium term, and 41 (16.6%) in the long term, non-significant results were found in 12 patients in the control at one week (4.6%), in 23 at three months (9.3%) and in 27 at six months (10.9%). In Group B, at the short-term follow-up we obtained an excellent clinical result in 103 patients (80.5%), while at three months 85 patients reported the persistence of clinical benefit (66.4%) and at six months, 72 (56.2%) reported the same result. The result was rated satisfactory in 11 (8.5%) and poor in 4 (3%). At the three-month follow-up, 23 (18%) reported a satisfactory result, and 20 (15.6%) had a poor result. At six months, 24 (18.8%) reported the persistence of a satisfactory result while for 32 the result was poor (25%).", "The results highlight how the treatment associated with ozone therapy and oral administration of alpha-lipoic acid + palmitoylethanolamide and myrrh can be considered a valid alternative to common therapeutic approaches in the treatment of chronic low back pain."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroradiology, Istituto Clinico Citt\u00e0 di Brescia, 25128 Brescia, Italy."}], "LastName": "Bonetti", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": ["0000-0002-3550-1812"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy."}], "LastName": "Lauritano", "ForeName": "Dorina", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Emergency and Urgency Department, Spedali Civili di Brescia, 25123 Brescia, Italy."}], "LastName": "Ottaviani", "ForeName": "Gian Maria", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroradiology, Istituto Clinico Citt\u00e0 di Brescia, 25128 Brescia, Italy."}], "LastName": "Fontana", "ForeName": "Alessandro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroradiology, Spedali Civili di Brescia, 25123 Brescia, Italy."}], "LastName": "Frigerio", "ForeName": "Michele", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Anesthesia and Pain Therapy Service, Casa di Cura Borghi, 21020 Brebbia, Italy."}], "LastName": "Zambello", "ForeName": "Alessio", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroradiology, Ospedale Cardarelli, 80131 Napoli, Italy."}], "LastName": "Della Gatta", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuroradiology, Ospedale Cardarelli, 80131 Napoli, Italy."}], "LastName": "Muto", "ForeName": "Mario", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy."}], "LastName": "Carinci", "ForeName": "Francesco", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chou R. Low back pain (chronic) BMJ Clin. Evid. 2010;2010:1116.", "ArticleIdList": ["PMC3217809", "21418678"]}, {"Citation": "Ehrlich G. Low back pain. Bull. World Health Organ. 2003;81:671\u2013676.", "ArticleIdList": ["PMC2572532", "14710509"]}, {"Citation": "Pellican\u00f2 G., Martinelli F., Tavanti V., Bonetti M., Leonardi M., Muto M., Villari N., Andreula C. The Italian Oxygen-Ozone Therapy Federation (FIO) study on oxygen- ozone treatment of herniated disc. Int. J. Ozone Ther. 2007;6:7\u201315."}, {"Citation": "Iliakis E., Valadakis V., Vynios D.H., Tsiganos C.P., Agapitos E. Rationalization of the activity of medical ozone on intervertebral disc and histological and biochemical study. Rivista di Neuroradiologia. 2001;14((Suppl. S1)):25\u201330. doi: 10.1177/19714009010140S105.", "ArticleIdList": ["10.1177/19714009010140S105"]}, {"Citation": "Gallucci M., Limbucci N., Zugaro L., Barile A., Stavroulis E., Ricci A., Galzio R., Masciocchi C. Sciatica: Treatment with Intradiscal and Intraforaminal Injections of Steroid and Oxygen-Ozone versus Steroid Only. Radiology. 2007;242:907\u2013913. doi: 10.1148/radiol.2423051934.", "ArticleIdList": ["10.1148/radiol.2423051934", "17209164"]}, {"Citation": "Splendiani A., Perri M., Conchiglia A., Fasano F., Di Egidio G., Masciocchi C., Gallucci M. MR Assessment of Lumbar Disk Herniation Treated with Oxygen-Ozone Diskolysis: The Role of DWI and Related ADC versus Intervertebral Disk Volumetric Analysis for Detecting Treatment Response. Neuroradiol. J. 2013;26:347\u2013356. doi: 10.1177/197140091302600316.", "ArticleIdList": ["10.1177/197140091302600316", "PMC5278852", "23859294"]}, {"Citation": "Zhang Y., Ma Y., Jiang J., Ding T., Wang J. Treatment of the lumbar disc herniation with intradiscal and intraforaminal injection of oxygen-ozone. J. Back Musculoskelet. Rehabil. 2013;26:317\u2013322. doi: 10.3233/BMR-130386.", "ArticleIdList": ["10.3233/BMR-130386", "23893147"]}, {"Citation": "Steppan J., Meaders T., Muto M., Murphy K.J. A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J. Vasc. Interv. Radiol. JVIR. 2010;21:534\u2013548. doi: 10.1016/j.jvir.2009.12.393.", "ArticleIdList": ["10.1016/j.jvir.2009.12.393", "20188591"]}, {"Citation": "Zennaro H., Dousset V., Viaud B., Allard M., Dehais J., S\u00e9n\u00e9gas J., Caill\u00e9 J.M. Periganglionic foraminal steroid injections performed under CT control. AJNR Am. J. Neuroradiol. 1998;19:349\u2013352.", "ArticleIdList": ["PMC8338162", "9504493"]}, {"Citation": "Cuckler J.M., Bernini P., Wiesel S.W., Booth R.E., Jr., Rothman R.H., Pickens G.T. The use of epidural steroids in the treatment of radicular pain. J. Bone Jt. Surg. Am. 1985;67:63\u201366. doi: 10.2106/00004623-198567010-00009.", "ArticleIdList": ["10.2106/00004623-198567010-00009", "3155742"]}, {"Citation": "Dougherty J.H., Fraser R.A.R. Complications involving intraspinal injections of steroids. Neurosurg. 1978;48:1023\u20131025. doi: 10.3171/jns.1978.48.6.1023.", "ArticleIdList": ["10.3171/jns.1978.48.6.1023", "580787"]}, {"Citation": "Rovira E., Garcia E.M., Catala J., Garcia J. Chronic adhesive arachnoiditis following epidural paramethasone. Rev. Neurol. 1997;25:2067\u20132068.", "ArticleIdList": ["9528075"]}, {"Citation": "Manfr\u00e8 L. Trattamento della lombosciatalgia acuta e cronica con infiltrazione perigangliare di steroide. Riv. Neuroradiol. 2001;14:43\u201346. doi: 10.1177/19714009010140S109.", "ArticleIdList": ["10.1177/19714009010140S109"]}, {"Citation": "Cyteval C., Thomas E., Decoux E., Sarrabere M.P., Cottin A., Blotman F., Taourel P. Cervical Radiculopathy: Open Study on Percutaneous Periradicular Foraminal Steroid Infiltration Performed under CT Control in 30 patients. AJNR Am. J. Neuroradiol. 2004;25:441\u2013445.", "ArticleIdList": ["PMC8158560", "15037470"]}, {"Citation": "Magalhaes F.N., Dotta L., Sasse A., Teixera M.J., Fonoff E.T. Ozone therapy as a treatment for low back pain secondary to herniated disc: A systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012;2:15.", "ArticleIdList": ["22430658"]}, {"Citation": "Perri M., Grattacaso G., Di Tunno V., Marsecano C., Di Cesare E., Splendiani A., Gallucci M. MRI DWI/ADC signal predicts shrinkage of lumbar disc herniation after O2-O3 discolysis. Neuroradiol. J. 2015;28:198\u2013204. doi: 10.1177/1971400915576658.", "ArticleIdList": ["10.1177/1971400915576658", "PMC4757152", "25923680"]}, {"Citation": "Rahimi-Movaghar V., Eslami V. The major efficient mechanisms of ozone therapy are obtained in intradiscal procedures. Pain Physician. 2012;15:E1007\u2013E1008. doi: 10.36076/ppj.2012/15/E1007.", "ArticleIdList": ["10.36076/ppj.2012/15/E1007", "23159972"]}, {"Citation": "Leonardi M., Simonetti L., Raffi L., Cenni P., Barbara C. Mini-Invasive Treatment of Herniated Disc by Oxygen-Ozone Injection. Interv. Neuroradiol. 2003;9((Suppl S2)):75. doi: 10.1177/15910199030090S211.", "ArticleIdList": ["10.1177/15910199030090S211", "PMC3556669", "20591285"]}, {"Citation": "Lehnert T., Naguib N.N., Wutzler S., Nour-Eldin N.E.A., Bauer R.W., Kerl J.M., Vogel T.J., Balzer J.O. Analysis of Disk Volume before and after CT-guided Intradiscal and Periganglionic Ozone\u2013Oxygen Injection for the Treatment of Lumbar Disk Herniation. J. Vasc. Interv. Radiol. 2012;23:1430\u20131436. doi: 10.1016/j.jvir.2012.07.029.", "ArticleIdList": ["10.1016/j.jvir.2012.07.029", "22999458"]}, {"Citation": "Re L., Sanchez G.M., Mawsouf N. Clinical evidence of ozone interaction with pain mediators. Saudi Med. J. 2010;31:1363\u20131367.", "ArticleIdList": ["21136002"]}, {"Citation": "Hidalgo-Tall\u00f3n F.J., Torres-Morera L.M., Baeza-Noci J., Carrillo-Izquierdo M.D., Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Front. Physiol. 2022;13:840623. doi: 10.3389/fphys.2022.840623.", "ArticleIdList": ["10.3389/fphys.2022.840623", "PMC8904924", "35283802"]}, {"Citation": "Hawkins C.L., Davies M.J. Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Radic. Biol. Med. 1996;21:275\u2013290. doi: 10.1016/0891-5849(96)00042-1.", "ArticleIdList": ["10.1016/0891-5849(96)00042-1", "8855438"]}, {"Citation": "de Sire A., Agostini F., Lippi L., Mangone M., Marchese S., Cisari C., Bernetti A., Invernizzi M. Oxygen\u2013Ozone Therapy in the Rehabilitation Field: State of the Art on Mechanisms of Action, Safety and Effectiveness in Patients with Musculoskeletal Disorders. Biomolecules. 2021;11:356. doi: 10.3390/biom11030356.", "ArticleIdList": ["10.3390/biom11030356", "PMC7996934", "33652804"]}, {"Citation": "Sconza C., Leonardi G., Kon E., Respizzi S., Massazza G., Marcacci M., Di Matteo B. Oxygen-ozone therapy for the treatment of low back pain: A systematic review of randomized controlled trials. Eur. Rev. Med. Pharmacol. Sci. 2021;25:6034\u20136046.", "ArticleIdList": ["34661263"]}, {"Citation": "Bonetti M., Lauritano D., Ottaviani G.M., Fontana A., Zambello A., Della Gatta L., Muto M., Carinci F. Oxygen-Ozone Therapy Associated with Alpha Lipoic Acid Plus Palmitoylethanolamide and Myrrh versus Ozone Therapy in the Combined Treatment of Sciatic Pain Due to Herniated Discs: Observational Study on 318 Patients. Int. J. Environ. Res. Public Health. 2022;19:5716. doi: 10.3390/ijerph19095716.", "ArticleIdList": ["10.3390/ijerph19095716", "PMC9100908", "35565111"]}, {"Citation": "Costantino M., Guaraldi C., Costantino D., De Grazia S., Unfer V. Peripheral neuropathy in obstetrics: Efficacy and safety of alpha lipoic acid supplementation. Eur. Rev. Med. Pharmacol. Sci. 2014;18:2766\u20132771.", "ArticleIdList": ["25317815"]}, {"Citation": "Matsugo S., Yan L.J., Han D., Trischler H.J., Packer L. Elucidation of antioxidant activity of alpha-lipoic acid towards hydroxyl radical. Biochem. Biophys. Res. Commun. 1995;208:161\u2013167. doi: 10.1006/bbrc.1995.1318.", "ArticleIdList": ["10.1006/bbrc.1995.1318", "7887924"]}, {"Citation": "Mijnhout G.S., Kollen B.J., Alkhalaf A., Kleefstra N., Bilo H.J.G. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: A meta-analysis of randomized controlled trials. Int. J. Endocrinol. 2012;201:456279. doi: 10.1155/2012/456279.", "ArticleIdList": ["10.1155/2012/456279", "PMC3272801", "22331979"]}, {"Citation": "Park S., Karunakaran U., Jeoung N.H., Jeon J.H., Lee I.K. Physiological effect and therapeutic application of alpha lipoic acid. Curr. Med. Chem. 2014;21:3636\u20133645. doi: 10.2174/0929867321666140706141806.", "ArticleIdList": ["10.2174/0929867321666140706141806", "25005184"]}, {"Citation": "Salehi B., Berkay Y\u0131lmaz Y., Antika G., Boyunegmez Tumer T., Fawzi Mahomoodally M., Lobine D., Akram M., Riaz M., Capanoglu E., Sharopov F., et al. Sharifi-Rad Insights on the Use of alpha-Lipoic Acid for Therapeutic Purposes. J. Biomol. 2019;9:356.", "ArticleIdList": ["PMC6723188", "31405030"]}, {"Citation": "Ziegler D., Ametov A.S., Barinov A., Dyck P.J., Gurieva I., Low P.A., Munzel U., Yakhno N., Raz I., Novosadova M., et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy. Diabetes Care. 2006;29:2365\u20132370. doi: 10.2337/dc06-1216.", "ArticleIdList": ["10.2337/dc06-1216", "17065669"]}, {"Citation": "Ziegler D., Hanefeld M., Ruhnau K.-J., Lobisch M., Sch\u00fctte K., Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid: A 3-week multicentre randomized controlled trial (ALADIN study) Diabetologia. 1995;38:1425\u20131433. doi: 10.1007/BF00400603.", "ArticleIdList": ["10.1007/BF00400603", "8786016"]}, {"Citation": "Bilska A., Wlodek L. Lipoic acid: The drug of the future? Pharm. Rep. 2005;57:570\u2013577.", "ArticleIdList": ["16227639"]}, {"Citation": "Han T., Bai J., Liu W., Hu Y. A systematic review and metanalysis of \u03b1-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur. J. Endocrinol. 2012;167:465\u2013471. doi: 10.1530/EJE-12-0555.", "ArticleIdList": ["10.1530/EJE-12-0555", "22837391"]}, {"Citation": "Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 1995;18:1160\u20131167. doi: 10.2337/diacare.18.8.1160.", "ArticleIdList": ["10.2337/diacare.18.8.1160", "7587852"]}, {"Citation": "El Ashry E.S., Rashed N., Salama O.M., Saleh A. Components, therapeutic value, and uses of myrrh. Pharmazie. 2003;58:163\u2013168.", "ArticleIdList": ["12685809"]}, {"Citation": "Nomicos E.Y. Myrrh: Medical marvel or myth of the Magi? Holist Nurs. Pract. 2007;21:308\u2013323. doi: 10.1097/01.HNP.0000298616.32846.34.", "ArticleIdList": ["10.1097/01.HNP.0000298616.32846.34", "17978635"]}, {"Citation": "Fernandez-Cuadros M.E., Albaladejo-Florin M.J., Martin-Martin L.M., Alava-Rabasa S., P\u00e9rez-Moro O.S. Effectiveness of Physical Therapy Plus TIOBEC\u00ae(\u03b1-Lipoic Acid Vitamin B, C, and E) on Complex Regional Pain Syndrome (CRPS): A Small Case Series/Pilot Study. Middle East J. Rehabil. Health Stud. 2020;7:e100636. doi: 10.5812/mejrh.100636.", "ArticleIdList": ["10.5812/mejrh.100636"]}, {"Citation": "Paladini A., Fusco M., Cenacchi T., Schievano P.C., Piroli A., Varrassi G. Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: A pooled data meta-analysis. Pain Physician. 2016;19:11\u201324.", "ArticleIdList": ["26815246"]}, {"Citation": "Dolara P., Luceri C., Ghelardini C., Monserrat C., Aiolli S., Luceri F., Lodovici M., Menichetti S., Romanelli M.N. Analgesic effects of myrrh. Nature. 1996;379:29. doi: 10.1038/379029a0.", "ArticleIdList": ["10.1038/379029a0", "8538737"]}, {"Citation": "Petrosino S., Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. J. Pharmacol. 2017;174:1349\u20131365. doi: 10.1111/bph.13580.", "ArticleIdList": ["10.1111/bph.13580", "PMC5429331", "27539936"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S., Casique-Bocanegra L.O., L\u00f3pez-Mu\u00f1oz M.J., Rodr\u00edguez-de-C\u00eda J., P\u00e9rez-Moro O.S. A nutraceutical combination of Alpha-lipoic acid, Palmitoylethanolamide and Myrrha might be effective in COVID-19 prevention. Lett. Ed./Med. Health Sci. 2020 doi: 10.24175/sbd.2020.000013.", "ArticleIdList": ["10.24175/sbd.2020.000013"]}, {"Citation": "Lo Verme J., La Rana G., Russo R., Calignano A., Piomelli D. The search for the palmitoylethanolamide receptor. Life Sci. 2005;77:1685\u20131698. doi: 10.1016/j.lfs.2005.05.012.", "ArticleIdList": ["10.1016/j.lfs.2005.05.012", "15963531"]}, {"Citation": "Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005;67:15\u201319. doi: 10.1124/mol.104.006353.", "ArticleIdList": ["10.1124/mol.104.006353", "15465922"]}, {"Citation": "Rankin L., Fowler C.J. The basal pharmacology of palmitoylethanolamide. Int. J. Mol. Sci. 2020;21:7942. doi: 10.3390/ijms21217942.", "ArticleIdList": ["10.3390/ijms21217942", "PMC7662788", "33114698"]}, {"Citation": "Gabrielsson L., Mattsson S., Fowler C.J. Palmitoylethanolamide for the treatment of pain: Pharmacokinetics, safety and efficacy. Br. J. Clin. Pharmacol. 2016;82:932\u2013942. doi: 10.1111/bcp.13020.", "ArticleIdList": ["10.1111/bcp.13020", "PMC5094513", "27220803"]}, {"Citation": "Alhouayek M., Muccioli G.G. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov. Today. 2014;19:1632\u20131639. doi: 10.1016/j.drudis.2014.06.007.", "ArticleIdList": ["10.1016/j.drudis.2014.06.007", "24952959"]}, {"Citation": "Esposito E., Cuzzocrea S. Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma. Mini-Rev. Med. Chem. 2013;13:237\u2013255.", "ArticleIdList": ["22697514"]}, {"Citation": "Hesselink J.M.K., de Boer T., Witkamp R.F. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold. Int. J. Inflamm. 2013;2013:151028. doi: 10.1155/2013/151028.", "ArticleIdList": ["10.1155/2013/151028", "PMC3771453", "24066256"]}, {"Citation": "Hesselink J.M.K., Hekker T.A. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: A case series. J. Pain Res. 2012;5:437. doi: 10.2147/JPR.S32143.", "ArticleIdList": ["10.2147/JPR.S32143", "PMC3500919", "23166447"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "11"}, {"Year": "2022", "Month": "12", "Day": "1"}, {"Year": "2022", "Month": "12", "Day": "22"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "1", "Minute": "13"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["36672581", "PMC9855610", "10.3390/biomedicines11010073", "biomedicines11010073"]}}], "PubmedBookArticle": []}